Literature DB >> 35834154

Predictive value of macular ganglion cell-inner plexiform layer thickness in visual field defect of pituitary adenoma patients: a case-control study.

Li Xia1,2, Jia Wenhui3, Yang Xiaowen4, Xie Wenfang2, Zhang Wei2, Hu Yanjun5, Peng Xiaoyan6.   

Abstract

OBJECTIVE: The present study explored the association between preoperative macular ganglion cell-inner plexiform layer thickness (GCIPL) and retinal nerve fiber layer thickness (RNFL) measured by optical coherence tomography (OCT) and the recovery of visual field (VF) defect after surgery in pituitary adenoma patients.
METHODS: This case-control study included patients with pituitary adenoma in the Neurosurgery Department of Shanxi Provincial People's Hospital between October 2019 and June 2021. Cranial MRI examination, three-dimensional OCT, and VF testing (Humphrey Field Analyzer II750) were performed before and at 6months after the surgery.
RESULTS: Fifty-three pituitary adenoma patients (81 eyes) were enrolled; 15 patients (23 eyes) were in the visual field did not recover group (VFNR), and 38 patients (58 eyes) were in the visual field recovered group (VFR). The temporal RNFL (P = 0.002) and average RNFL (P = 0.009) in the VFNR group were significantly lower than in the VFR group. The superior nasal GCIPL (P = 0.001), inferior nasal GCIPL (P = 0.001) and average GCIPL (P = 0.01) were significantly lower in the VFNR group than in the VFR group (all P < 0.01).The multivariable logistic regression analysis showed that nasal inferior GCIPL was an independent risk factor for VF recovery (odds ratio (OR) = 1.376,95% confidence interval (CI):1.089-1.739,P = 0.007). In the received operating characteristics (ROC) analysis, the area under the ROC curve (AUROCs) was the highest for nasal inferior GCIPL (AUROC = 0.739).
CONCLUSIONS: In patients who underwent resection of pituitary adenoma, nasal inferior GCIPL was an independent risk factor of visual field defect recover after surgery.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Case-control; Optical coherence tomography; Pituitary adenoma; Visual filed defect

Mesh:

Year:  2022        PMID: 35834154     DOI: 10.1007/s11102-022-01248-6

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   3.599


  18 in total

Review 1.  Visual function in children with primary brain tumors.

Authors:  Jason H Peragallo
Journal:  Curr Opin Neurol       Date:  2019-02       Impact factor: 5.710

Review 2.  Optical coherence tomography as a marker of vision in children with optic pathway gliomas.

Authors:  Ana Banc; Cristina Stan; Ioan Stefan Florian
Journal:  Childs Nerv Syst       Date:  2017-08-26       Impact factor: 1.475

Review 3.  Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.

Authors:  Georgia Ntali; John A Wass
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

4.  Optical coherence tomography predicts visual outcome for pituitary tumors.

Authors:  Helen V Danesh-Meyer; Aaron Wong; Taras Papchenko; Kaliopy Matheos; Stanley Stylli; Andrew Nichols; Chris Frampton; Mark Daniell; Peter J Savino; Andrew H Kaye
Journal:  J Clin Neurosci       Date:  2015-04-16       Impact factor: 1.961

5.  Preferential Ganglion Cell Loss in the Nasal Hemiretina in Patients With Pituitary Tumor.

Authors:  Ah Reum Jeong; Eun-Young Kim; Na Rae Kim
Journal:  J Neuroophthalmol       Date:  2016-06       Impact factor: 3.042

Review 6.  Does Retinal Ganglion Cell Loss Precede Visual Field Loss in Glaucoma?

Authors:  Donald C Hood
Journal:  J Glaucoma       Date:  2019-11       Impact factor: 2.503

Review 7.  Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography: update 2022.

Authors:  Kenichi Fujii; Takashi Kubo; Hiromasa Otake; Gaku Nakazawa; Shinjo Sonoda; Kiyoshi Hibi; Toshiro Shinke; Yoshio Kobayashi; Yuji Ikari; Takashi Akasaka
Journal:  Cardiovasc Interv Ther       Date:  2022-02-15

Review 8.  The Effects of Primary Brain Tumors on Vision and Quality of Life in Pediatric Patients.

Authors:  Supharat Jariyakosol; Jason H Peragallo
Journal:  Semin Neurol       Date:  2015-10-06       Impact factor: 3.420

Review 9.  Optical coherence tomography: A guide to interpretation of common macular diseases.

Authors:  Muna Bhende; Sharan Shetty; Mohana Kuppuswamy Parthasarathy; S Ramya
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

10.  Progressive loss of vision caused by asymptomatic pituitary macroadenoma: role of OCT.

Authors:  Víctor Manuel Asensio-Sánchez; Javier Foncubierta
Journal:  Int Med Case Rep J       Date:  2016-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.